|
Index of reports
> Cases resulting in hospitalization (9)
> Cases with Diabetes Mellitus (2)
Below is the selection of adverse event reports related to Estratest (Esterified Estrogens) that includes cases resulting in hospitalization where reactions include diabetes mellitus.
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a lawyer from United States on 2007-03-20
Patient: female
Adverse reactions / side effects: Breast Cancer, Diabetes Mellitus, Pancreatitis, Cerebrovascular Accident
Adverse event resulted in: hospitalization
Suspect drug(s):
Prempro
0.1mg Levonorgestrel / 0.02mg Ethinyl Estradiol / Inert
Medroxyprogesterone Acetate
Depo-Provera
Estratest
Medroxyprogesterone Acetate
Indication: Hormone Replacement Therapy
Premarin
Other drugs received by patient: Glucophage; Lopid; Pravachol; Ativan; Ascorbic Acid; Vitamin B Complex CAP; Synthroid
Adverse event in 58 year old female receiving Estratest (Esterified Estrogens)
Reported by a physician from United States on 2007-03-15
Patient: 58 year old female
Adverse reactions / side effects: Pulmonary Hypertension, Biopsy Breast Abnormal, Diabetes Mellitus, Dilatation Ventricular, Tricuspid Valve Incompetence, Treatment Noncompliance, Surgery, Atrial Hypertrophy, Oedema Peripheral, Breast Hyperplasia, Echocardiogram, Back Pain, Supraventricular Tachycardia, Breast Cancer Female, Cholelithiasis, Ventricular Dysfunction, Cholecystectomy, Homicidal Ideation, Scan Myocardial Perfusion Abnormal, Head Injury, Breast Cancer Stage IV, Pain, Hemiparesis, Fall, Fatigue, Fibrocystic Breast Disease, Coronary Artery Bypass, Dizziness, Lymphoedema, Atrial Flutter, Urinary Tract Infection, Atrial Fibrillation, Cerebrovascular Accident, Cardiac Pacemaker Insertion, Arthralgia, Mitral Valve Incompetence, Infarction
Adverse event resulted in: hospitalization
Suspect drug(s):
Vivelle
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
Premarin
Dosage: 10 mg, unk
Administration route: Oral
End date: 1996-08-01
Provera
Dosage: 0.625 mg, unk
Administration route: Oral
End date: 1996-08-01
Cycrin
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
Curretab
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
Estrace
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
MPA
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
Estratest
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
Prempro
Dosage: 0.625/25 mg, unk
Indication: Hormone Replacement Therapy
Start date: 1996-08-01
End date: 2002-08-01
|
